These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 35998677)

  • 1. The gut microbiota - A vehicle for the prevention and treatment of hepatocellular carcinoma.
    Beyoğlu D; Idle JR
    Biochem Pharmacol; 2022 Oct; 204():115225. PubMed ID: 35998677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbial dysbiosis associates hepatocellular carcinoma via the gut-liver axis.
    Jiang JW; Chen XH; Ren Z; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2019 Feb; 18(1):19-27. PubMed ID: 30527903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease.
    Suk KT; Kim DJ
    Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):193-204. PubMed ID: 30791767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives.
    Vallianou N; Christodoulatos GS; Karampela I; Tsilingiris D; Magkos F; Stratigou T; Kounatidis D; Dalamaga M
    Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota and host metabolism in liver cirrhosis.
    Usami M; Miyoshi M; Yamashita H
    World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The double-edged sword of probiotic supplementation on gut microbiota structure in
    Nabavi-Rad A; Sadeghi A; Asadzadeh Aghdaei H; Yadegar A; Smith SM; Zali MR
    Gut Microbes; 2022; 14(1):2108655. PubMed ID: 35951774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota dysbiosis in patients with hepatitis B virus-induced chronic liver disease covering chronic hepatitis, liver cirrhosis and hepatocellular carcinoma.
    Zeng Y; Chen S; Fu Y; Wu W; Chen T; Chen J; Yang B; Ou Q
    J Viral Hepat; 2020 Feb; 27(2):143-155. PubMed ID: 31600845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered gut microbiota in hepatocellular carcinoma: Insights into the pathogenic mechanism and preclinical to clinical findings.
    Das BK
    APMIS; 2022 Dec; 130(12):719-740. PubMed ID: 36321381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bile acids, gut microbiota, and therapeutic insights in hepatocellular carcinoma.
    Song Y; Lau HC; Zhang X; Yu J
    Cancer Biol Med; 2023 Dec; 21(2):144-62. PubMed ID: 38148326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites.
    Zhang X; Coker OO; Chu ES; Fu K; Lau HCH; Wang YX; Chan AWH; Wei H; Yang X; Sung JJY; Yu J
    Gut; 2021 Apr; 70(4):761-774. PubMed ID: 32694178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gut microbiome-bile acid axis in hepatocarcinogenesis.
    Wu L; Feng J; Li J; Yu Q; Ji J; Wu J; Dai W; Guo C
    Biomed Pharmacother; 2021 Jan; 133():111036. PubMed ID: 33378947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unveiling the complex relationship between gut microbiota and liver cancer: opportunities for novel therapeutic interventions.
    Rajapakse J; Khatiwada S; Akon AC; Yu KL; Shen S; Zekry A
    Gut Microbes; 2023 Dec; 15(2):2240031. PubMed ID: 37615334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inulin Ameliorates Alcoholic Liver Disease via Suppressing LPS-TLR4-Mψ Axis and Modulating Gut Microbiota in Mice.
    Yang X; He F; Zhang Y; Xue J; Li K; Zhang X; Zhu L; Wang Z; Wang H; Yang S
    Alcohol Clin Exp Res; 2019 Mar; 43(3):411-424. PubMed ID: 30589437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms by Which Probiotic Bacteria Attenuate the Risk of Hepatocellular Carcinoma.
    Thilakarathna WPDW; Rupasinghe HPV; Ridgway ND
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of gut microbiome in nonalcoholic fatty liver disease: pro-, pre-, syn-, and antibiotics.
    Cho MS; Kim SY; Suk KT; Kim BY
    J Microbiol; 2018 Dec; 56(12):855-867. PubMed ID: 30377993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining the temporal evolution of gut dysbiosis and inflammatory responses leading to hepatocellular carcinoma in Mdr2 -/- mouse model.
    Behary J; Raposo AE; Amorim NML; Zheng H; Gong L; McGovern E; Chen J; Liu K; Beretov J; Theocharous C; Jackson MT; Seet-Lee J; McCaughan GW; El-Omar EM; Zekry A
    BMC Microbiol; 2021 Apr; 21(1):113. PubMed ID: 33858327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota, cirrhosis, and alcohol regulate bile acid metabolism in the gut.
    Ridlon JM; Kang DJ; Hylemon PB; Bajaj JS
    Dig Dis; 2015; 33(3):338-45. PubMed ID: 26045267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin prevents fermentable fiber-induced liver cancer in mice with dysbiotic gut microbiota.
    Singh V; Yeoh BS; Abokor AA; Golonka RM; Tian Y; Patterson AD; Joe B; Heikenwalder M; Vijay-Kumar M
    Gut Microbes; 2020 Jul; 11(4):1077-1091. PubMed ID: 32223398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Gut Microbial Metabolites in the Pathogenesis of Primary Liver Cancers.
    Pallozzi M; De Gaetano V; Di Tommaso N; Cerrito L; Santopaolo F; Stella L; Gasbarrini A; Ponziani FR
    Nutrients; 2024 Jul; 16(14):. PubMed ID: 39064815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response.
    Yan F; Zhang Q; Shi K; Zhang Y; Zhu B; Bi Y; Wang X
    Front Cell Infect Microbiol; 2023; 13():1152987. PubMed ID: 37201112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.